BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Gastric cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [